Nuvama lists out 4 reasons why they have rated MphasiS Buy. However they have a revised the price target lower. Find out why?

Investor concerns over the renewable energy sector's near-term prospects were evident on Friday, with Adani Green Energy ...

Nuvama Wealth Management announced the date to declare its third-quarter FY2024-25 results on Friday, January 24. Shares were ...

The brokerage firm, Nuvama, has raised its target price for UltraTech Cement to Rs 11,574 per share while maintaining its ...

Spandana Sphoorty shares hit lower circuit after it reported a net loss of ₹394 crore for the quarter ended December 2024 as ...

The generic drugmaker was the top loser on the Nifty Pharma index and the benchmark Nifty 50 index. "The drop in shares comes ...

ICICI Banks net interest income for the third quarter is projected to grow 10% YoY, while PAT is expected to rise 8% YoY, ...

Cyient's profit fell 31.7 per cent quarter-on-quarter (Q-o-Q) to Rs 122.3 crore in Q3FY25, from 179.1 crore in the September ...

NewsVoir Mumbai Maharashtra [India] January 24 The modern workplace continues to evolve beyond aesthetics and UrbanWrk a ...

Brokerages praise UltraTech Cement's Q3 performance, foreseeing market share gains and future growth despite profit decline ...

At around 10:21 am, shares of Cyient were down 17.96% to Rs 1,438 on the Bombay Stock Exchange (BSE). In early trade, shares ...

India's Orient Cement reported a slump in third-quarter profit on Friday due to weak prices of the key construction material amid seasonally low demand.